Severity Biomarkers in Puumala Hantavirus Infection

Annually, over 10,000 cases of hemorrhagic fever with renal syndrome (HFRS) are diagnosed in Europe. Puumala hantavirus (PUUV) causes most of the European HFRS cases. PUUV causes usually a relatively mild disease, which is rarely fatal. However, the severity of the infection varies greatly, and fact...

Full description

Bibliographic Details
Main Authors: Tuula K. Outinen, Satu Mäkelä, Ilkka Pörsti, Antti Vaheri, Jukka Mustonen
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/1/45
_version_ 1827662195212681216
author Tuula K. Outinen
Satu Mäkelä
Ilkka Pörsti
Antti Vaheri
Jukka Mustonen
author_facet Tuula K. Outinen
Satu Mäkelä
Ilkka Pörsti
Antti Vaheri
Jukka Mustonen
author_sort Tuula K. Outinen
collection DOAJ
description Annually, over 10,000 cases of hemorrhagic fever with renal syndrome (HFRS) are diagnosed in Europe. Puumala hantavirus (PUUV) causes most of the European HFRS cases. PUUV causes usually a relatively mild disease, which is rarely fatal. However, the severity of the infection varies greatly, and factors affecting the severity are mostly unrevealed. Host genes are known to have an effect. The typical clinical features in PUUV infection include acute kidney injury, thrombocytopenia, and increased vascular permeability. The primary target of hantavirus is the endothelium of the vessels of different organs. Although PUUV does not cause direct cytopathology of the endothelial cells, remarkable changes in both the barrier function of the endothelium and the function of the infected endothelial cells occur. Host immune or inflammatory mechanisms are probably important in the development of the capillary leakage. Several immunoinflammatory biomarkers have been studied in the context of assessing the severity of HFRS caused by PUUV. Most of them are not used in clinical practice, but the increasing knowledge about the biomarkers has elucidated the pathogenesis of PUUV infection.
first_indexed 2024-03-10T00:21:43Z
format Article
id doaj.art-4aadd0ed94754cedab2080fb255932ab
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T00:21:43Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-4aadd0ed94754cedab2080fb255932ab2023-11-23T15:41:16ZengMDPI AGViruses1999-49152021-12-011414510.3390/v14010045Severity Biomarkers in Puumala Hantavirus InfectionTuula K. Outinen0Satu Mäkelä1Ilkka Pörsti2Antti Vaheri3Jukka Mustonen4Department of Internal Medicine, Tampere University Hospital, Elämänaukio 2, 33520 Tampere, FinlandDepartment of Internal Medicine, Tampere University Hospital, Elämänaukio 2, 33520 Tampere, FinlandDepartment of Internal Medicine, Tampere University Hospital, Elämänaukio 2, 33520 Tampere, FinlandDepartment of Virology, Medicum, University of Helsinki, 00290 Helsinki, FinlandDepartment of Internal Medicine, Tampere University Hospital, Elämänaukio 2, 33520 Tampere, FinlandAnnually, over 10,000 cases of hemorrhagic fever with renal syndrome (HFRS) are diagnosed in Europe. Puumala hantavirus (PUUV) causes most of the European HFRS cases. PUUV causes usually a relatively mild disease, which is rarely fatal. However, the severity of the infection varies greatly, and factors affecting the severity are mostly unrevealed. Host genes are known to have an effect. The typical clinical features in PUUV infection include acute kidney injury, thrombocytopenia, and increased vascular permeability. The primary target of hantavirus is the endothelium of the vessels of different organs. Although PUUV does not cause direct cytopathology of the endothelial cells, remarkable changes in both the barrier function of the endothelium and the function of the infected endothelial cells occur. Host immune or inflammatory mechanisms are probably important in the development of the capillary leakage. Several immunoinflammatory biomarkers have been studied in the context of assessing the severity of HFRS caused by PUUV. Most of them are not used in clinical practice, but the increasing knowledge about the biomarkers has elucidated the pathogenesis of PUUV infection.https://www.mdpi.com/1999-4915/14/1/45hantavirushemorrhagic fever with renal syndromePuumala virusbiomarker
spellingShingle Tuula K. Outinen
Satu Mäkelä
Ilkka Pörsti
Antti Vaheri
Jukka Mustonen
Severity Biomarkers in Puumala Hantavirus Infection
Viruses
hantavirus
hemorrhagic fever with renal syndrome
Puumala virus
biomarker
title Severity Biomarkers in Puumala Hantavirus Infection
title_full Severity Biomarkers in Puumala Hantavirus Infection
title_fullStr Severity Biomarkers in Puumala Hantavirus Infection
title_full_unstemmed Severity Biomarkers in Puumala Hantavirus Infection
title_short Severity Biomarkers in Puumala Hantavirus Infection
title_sort severity biomarkers in puumala hantavirus infection
topic hantavirus
hemorrhagic fever with renal syndrome
Puumala virus
biomarker
url https://www.mdpi.com/1999-4915/14/1/45
work_keys_str_mv AT tuulakoutinen severitybiomarkersinpuumalahantavirusinfection
AT satumakela severitybiomarkersinpuumalahantavirusinfection
AT ilkkaporsti severitybiomarkersinpuumalahantavirusinfection
AT anttivaheri severitybiomarkersinpuumalahantavirusinfection
AT jukkamustonen severitybiomarkersinpuumalahantavirusinfection